| Memory loss in Alzheimer's disease H Jahn Dialogues in clinical neuroscience 15 (4), 445-454, 2013 | 753 | 2013 |
| Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus SM Stobrawa, T Breiderhoff, S Takamori, D Engel, M Schweizer, ... Neuron 29 (1), 185-196, 2001 | 599 | 2001 |
| Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease DM Good, P Zürbig, A Argiles, HW Bauer, G Behrens, JJ Coon, M Dakna, ... Molecular & cellular proteomics 9 (11), 2424-2437, 2010 | 572 | 2010 |
| Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study F Kiefer, H Jahn, T Tarnaske, H Helwig, P Briken, R Holzbach, P Kämpf, ... Archives of general psychiatry 60 (1), 92-99, 2003 | 558 | 2003 |
| Executive functioning in obsessive–compulsive disorder, unipolar depression, and schizophrenia S Moritz, C Birkner, M Kloss, H Jahn, I Hand, C Haasen, M Krausz Archives of Clinical Neuropsychology 17 (5), 477-483, 2002 | 478 | 2002 |
| Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho‐Tau in patients with low‐and high‐CSF Aβ40 load J Wiltfang, H Esselmann, M Bibl, M Hüll, H Hampel, H Kessler, L Frölich, ... Journal of neurochemistry 101 (4), 1053-1059, 2007 | 333 | 2007 |
| MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimers disease J Denk, K Boelmans, C Siegismund, D Lassner, S Arlt, H Jahn PloS one 10 (5), e0126423, 2015 | 243 | 2015 |
| Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease M Wagner, S Wolf, FM Reischies, M Daerr, S Wolfsgruber, F Jessen, ... Neurology 78 (6), 379-386, 2012 | 206 | 2012 |
| Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study P Lewczuk, H Kamrowski-Kruck, O Peters, I Heuser, F Jessen, J Popp, ... Molecular psychiatry 15 (2), 138-145, 2010 | 204 | 2010 |
| Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial H Jahn, M Schick, F Kiefer, M Kellner, A Yassouridis, K Wiedemann Archives of general psychiatry 61 (12), 1235-1244, 2004 | 200 | 2004 |
| Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type J Popp, S Wolfsgruber, I Heuser, O Peters, M Hüll, J Schröder, HJ Möller, ... Neurobiology of aging 36 (2), 601-607, 2015 | 179 | 2015 |
| Investigations on CXCL13 in anti–N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response F Leypoldt, R Höftberger, MJ Titulaer, T Armangue, N Gresa-Arribas, ... JAMA neurology 72 (2), 180-186, 2015 | 173 | 2015 |
| Site‐specific phosphorylation of the purified receptor for calcium‐channel blockers by cAMP‐and cGMP‐dependent protein kinases, protein kinase C, calmodulin‐dependent protein … H Jahn, W Nastainczyk, A RöHRKASTEN, T Schneider, F Hofmann European journal of biochemistry 178 (2), 535-542, 1988 | 168 | 1988 |
| Elevation of β-amyloid peptide 2–42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells J Wiltfang, H Esselmann, P Cupers, M Neumann, H Kretzschmar, ... Journal of Biological Chemistry 276 (46), 42645-42657, 2001 | 162 | 2001 |
| Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing P Lewczuk, J Kornhuber, E Vanmechelen, O Peters, I Heuser, W Maier, ... Experimental Neurology 223 (2), 366-370, 2010 | 153 | 2010 |
| Leptin: a modulator of alcohol craving? F Kiefer, H Jahn, M Jaschinski, R Holzbach, K Wolf, D Naber, ... Biological Psychiatry 49 (9), 782-787, 2001 | 153 | 2001 |
| High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types S Doss, KP Wandinger, BT Hyman, JA Panzer, M Synofzik, B Dickerson, ... Annals of clinical and translational neurology 1 (10), 822-832, 2014 | 147 | 2014 |
| Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study C Otte, K Hinkelmann, S Moritz, A Yassouridis, H Jahn, K Wiedemann, ... Journal of psychiatric research 44 (6), 339-346, 2010 | 146 | 2010 |
| Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers H Jahn, S Wittke, P Zürbig, TJ Raedler, S Arlt, M Kellmann, W Mullen, ... PloS one 6 (10), e26540, 2011 | 141 | 2011 |
| Pharmacological relapse prevention of alcoholism: clinical predictors of outcome F Kiefer, H Helwig, T Tarnaske, C Otte, H Jahn, K Wiedemann European Addiction Research 11 (2), 83-91, 2005 | 139 | 2005 |
